UDG to sell Irish arm for €407.5m to McKesson

UDG Healthcare has announced that the proposed €407.5m sale of its Irish pharmaceutical distribution businesses has been approved by shareholders at an EGM this afternoon.

On September 18 the FTSE 250 healthcare services business announced the proposed sale of its United Drug Supply Chain Services business, United Drug Sangers business, TCP Group, as well as its British-based travel healthcare business MASTA, to McKesson, a global pharmaceutical wholesaler and retail pharmacy group (one of ...